Outcome of Patients with Pathological Tumor Stage T3 Urothelial Carcinoma of the Bladder following Radical Cystectomy in a Single-Center Series with 116 Patients.

Autor: Breyer, Johannes, Denzinger, Stefan, Otto, Wolfgang, Bründl, Johannes, Gierth, Michael, Fritsche, Hans-Martin, Rößler, Wolfgang, Wieland, Wolf F., Giedl, Christian, Hofstädter, Ferdinand, Rubenwolf, Peter, Burger, Maximilian, aziz, atiqullah
Předmět:
Zdroj: Urologia Internationalis; Oct2014, Vol. 93 Issue 3, p311-319, 9p, 1 Diagram, 2 Charts, 3 Graphs
Abstrakt: Objective: Outcome prediction of pT3 urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC) remains challenging. The objective of our study was to determine high-risk patients with poor survival outcome in a heterogeneous group substaged pT3 who might profit from early adjuvant chemotherapy. Materials and Methods: We compiled clinicopathological and immunohistochemical data of E-cadherin (E-cad) expression in 116 patients with pT3 UCB after RC in our single-center series. Multivariable Cox regression models including substaged pT3 established clinicopathological features, and the expression of the predictive immunohistochemical feature E-cad was used to identify independent predictors on progression-free (PFS), cancer-specific (CSS) and overall survival (OS), respectively. Results: No significant differences were found addressing clinicopathological data and substaged pT3. In multivariable Cox regression models, lymph node involvement was an independent predictor for PFS (p < 0.001), CSS (p < 0.001) and OS (p = 0.002), respectively. Lymphovascular invasion (LVI) significantly influenced PFS (p = 0.016). ASA score 3/4 independently predicted CSS (p = 0.049) and OS (p = 0.032). Neither pT3 substages nor E-cad expression were significant prognosticators for survival. Conclusions: In pT3 UCB patients with ASA 3/4, positive lymph node status and/or presence of LVI, administration of chemotherapy should be considered due to the high risk of poor oncological outcome. The immunohistochemical marker E-cad was not an independent predictor. © 2014 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index